The study of cases administrated Daikenchuto suppositories for paralytic ileus in terminally ill cancer patients.

The study of cases administrated Daikenchuto suppositories for paralytic ileus in terminally ill cancer patients. - Effect of Daikenchuto suppositories for paralytic ileus.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000025687

Enrollment

Registered

2017-01-16

Start date

2017-01-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

We have prepared Daikenchuto suppositories to administrate for 60 patients who have ileus with nausea or vomiting.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: terminally ill cancer patients with paralytic ileus.

Exclusion criteria

Exclusion criteria: 1) A patiet with stenosis or bleeding of rectum or recatal cancer 2) A patient who rejectes the administration.

Design outcomes

Primary

Measure	Time frame
Palliative Prognostic Index(PPI) on admission	—

Secondary

Measure	Time frame
Improvement rates of nausea, vomiting, abdominal pain, oral intake resumes and hospitalization, combination with Octreotide, complication of peritoneal dissemination.	—

Countries

Japan

Contacts

Public ContactToshiyuki Takeshige

Fukushima Medical University, Aizu Medical Center Palliative Care

takesige1@msn.com0242-75-2100

Outcome results